Sodium Iodide → HCID 68550400, compound
Reaction equation
[Cl:1][CH:2]([CH3:17])[C:3]([C:5]1[C:6]([CH:14]([CH3:16])[CH3:15])=[N:7][N:8]2[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=12)=[O:4].C([N:25]1[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]1)(OC(C)(C)C)=O.[Na+].[I-]>CO>[ClH:1].[CH:14]([C:6]1[C:5]([C:3](=[O:4])[CH:2]([N:25]2[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]2)[CH3:17])=[C:9]2[CH:10]=[CH:11][CH:12]=[CH:13][N:8]2[N:7]=1)([CH3:16])[CH3:15]Participants
5
Conditions
- Temperature
- 60 °C
Procedure
A mixture of 980 mg (3.90 mmol) of 2-chloro-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one, 1.45 g (4 mmol) of N-Boc-piperazine and 100 mg of NaI in 10 ml of MeOH was stirred at 50-70° C. for 5 hours. The residue obtained after evaporation of the solvent was purified on an Al2O3 column. The fractions containing purified product were titrated with 4N HCl-dioxane to obtain a precipitate. Recrystallization from isopropanol/ether produced 150 mg of 1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-(piperazin-1-yl)propan-1-one hydrochloride. Compound 1037.
Workup
- customThe residue obtained
- customafter evaporation of the solvent
- customwas purified on an Al2O3 column
- additionThe fractions containing
- custompurified product
- customto obtain a precipitate
- customRecrystallization from isopropanol/ether
Sources & evidence
- ORD record
- ord-f6330fabecd14853b8eafcfc1d8329c0
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07585875B2
Reaction notes
Loading…